| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Robert B Raffa, Andrea F Martle. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain research. vol 1031. issue 1. 2005-03-18. PMID:15621023. |
these findings strengthen the hypothesis that the effects of dopaminergic ligands and uv light on plmv relate to interaction with neurotransmitter transduction process(es). |
2005-03-18 |
2023-08-12 |
Not clear |
| Giuseppe Fanciulli, Alessandra Dettori, Maria P Demontis, Paolo A Tomasi, Vittorio Anania, Giuseppe Delital. Gluten exorphin B5 stimulates prolactin secretion through opioid receptors located outside the blood-brain barrier. Life sciences. vol 76. issue 15. 2005-03-10. PMID:15698850. |
since opioid peptides do not exert their effect on prl secretion directly, but via a reduced dopaminergic tone, our data suggest that ge-b5 can modify brain neurotransmitter release without crossing the bbb. |
2005-03-10 |
2023-08-12 |
rat |
| E Catalani, C Gangitano, L Bosco, G Casin. Expression of the neurokinin 1 receptor in the mouse retina. Neuroscience. vol 128. issue 3. 2005-03-04. PMID:15381281. |
different subsets of nk1 receptor-expressing amacrine cells were identified on the basis of the expression of selected neurotransmitter substances: i) about 23% of nk1 receptor-expressing amacrine cells also contained glycine; ii) the remaining 77% were likely to be gabaergic, although some inconsistency was observed in the gaba immunostaining obtained with two different gaba antibodies; iii) all dopaminergic amacrine cells also expressed nk1 receptors; iv) about one third of sp-containing amacrine cells also expressed nk1 receptors. |
2005-03-04 |
2023-08-12 |
mouse |
| Waguih William Ishak, Mark H Rapaport, Jennifer G Gott. The effectiveness of atypical antipsychotic medications in depressive disorders. Current psychiatry reports. vol 6. issue 6. 2005-03-02. PMID:15538989. |
animal models suggest that when atypical antipsychotic medications are used in combination with a selective serotonin reuptake inhibitor there is additional activation of frontal dopaminergic and noradrenergic neurotransmitter systems. |
2005-03-02 |
2023-08-12 |
Not clear |
| B Aouizerate, C Martin-Guehl, J Tigno. [Neurobiology and pharmacotherapy of social phobia]. L'Encephale. vol 30. issue 4. 2005-03-01. PMID:15538306. |
several lines of evidence suggest specific neurotransmitter system alterations in social phobia, especially with regard to the serotoninergic, noradrenergic and dopaminergic systems. |
2005-03-01 |
2023-08-12 |
human |
| Ilonka A T M Meerts, Hellmuth Lilienthal, Saske Hoving, Johannes H J van den Berg, Bert M Weijers, Ake Bergman, Jan H Koeman, Abraham Brouwe. Developmental exposure to 4-hydroxy-2,3,3',4',5-pentachlorobiphenyl (4-OH-CB107): long-term effects on brain development, behavior, and brain stem auditory evoked potentials in rats. Toxicological sciences : an official journal of the Society of Toxicology. vol 82. issue 1. 2005-02-22. PMID:15310863. |
measurements of neurotransmitter levels revealed effects of aroclor 154 exposure on both the dopaminergic and the serotonergic systems, whereas 4-oh-cb107 exposure affected dopaminergic and noradrenergic systems, with slight but not significant effects on the serotonergic system. |
2005-02-22 |
2023-08-12 |
rat |
| E Dalfó, J L Albasanz, M Martin, I Ferre. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions. Brain pathology (Zurich, Switzerland). vol 14. issue 4. 2005-02-14. PMID:15605986. |
several neurotransmitter abnormalities have been reported including those of the nigrostriatal and mesocorticolimbic dopaminergic system, and central noradrenergic, serotoninergic and cholinergic pathways. |
2005-02-14 |
2023-08-12 |
Not clear |
| G Skuza, K Wedzon. Behavioral pharmacology of sigma-ligands. Pharmacopsychiatry. vol 37 Suppl 3. 2005-02-04. PMID:15547784. |
although the precise mechanism of the functional response of these receptors is still uncertain, it is accepted that sigma receptors can modulate a number of central neurotransmitter systems, including noradrenergic, glutamatergic and dopaminergic ones. |
2005-02-04 |
2023-08-12 |
human |
| C L Kuo, R B Wang, L J Shen, L L Lien, E J Lie. G-protein coupled receptors: SAR analyses of neurotransmitters and antagonists. Journal of clinical pharmacy and therapeutics. vol 29. issue 3. 2005-01-06. PMID:15153091. |
from the deductive point of view, neurotransmitter receptors can be divided into categories such as cholinergic (muscarinic, nicotinic), adrenergic (alpha- and beta-), dopaminergic, serotoninergic (5-ht1 approximately 5-ht5), and histaminergic (h1 and h2). |
2005-01-06 |
2023-08-12 |
Not clear |
| Yitzchak Frank, Robert G Pergolizzi, Mindy J Perill. Dopamine D4 receptor gene and attention deficit hyperactivity disorder. Pediatric neurology. vol 31. issue 5. 2005-01-03. PMID:15519116. |
its pathophysiology is thought to involve an abnormality of the brain's dopaminergic neurotransmitter system. |
2005-01-03 |
2023-08-12 |
human |
| Vandana Zaman, Matthew E Nelson, Greg A Gerhardt, Baerbel Rohre. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice. Experimental neurology. vol 190. issue 2. 2004-12-29. PMID:15530873. |
these data suggest that elevated neurotransmitter and neurotrophic factor levels might be a compensatory mechanism following dopaminergic cell loss in the sn. |
2004-12-29 |
2023-08-12 |
mouse |
| Tomás González-Hernández, Pedro Barroso-Chinea, Manuel Rodrígue. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat. Movement disorders : official journal of the Movement Disorder Society. vol 19. issue 9. 2004-12-21. PMID:15372592. |
although dopamine is the main neurotransmitter in the mesostriatal system, recent studies indicate the existence of two nigrostriatal gabaergic projections: one arising from neurons immunoreactive for gaba, glutamic acid decarboxylase (gad67), and parvalbumin (pv) lying in the substantia nigra pars reticulata (nigrostriatal gaba cells) and the other arising from a subpopulation of dopaminergic neurons lying in the substantia nigra pars compacta and ventral tegmental area, which under normal conditions, contains mrna for gad65 (one of the two isoforms of glutamic acid decarboxylase), but which is not immunoreactive for gaba and gad65 (nigrostriatal dopaminergic [da]/gaba cells). |
2004-12-21 |
2023-08-12 |
rat |
| Shun Yu, Xiaohong Zuo, Yaohua Li, Chen Zhang, Ming Zhou, Yu Alex Zhang, Kenji Uéda, Piu Cha. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neuroscience letters. vol 367. issue 1. 2004-11-24. PMID:15308292. |
although the aberrant expression of alpha-synuclein (alpha-syn) is toxic to dopaminergic neurons, little is known about the correlation between the abnormality of alpha-syn and the expression of tyrosine hydroxylase (th), a rate-limiting enzyme for the synthesis of dopamine neurotransmitter. |
2004-11-24 |
2023-08-12 |
human |
| R Ceravolo, D Volterrani, G Gambaccini, S Bernardini, C Rossi, C Logi, G Tognoni, G Manca, G Mariani, U Bonuccelli, L Murr. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. Journal of neural transmission (Vienna, Austria : 1996). vol 111. issue 8. 2004-11-19. PMID:15254794. |
the lack of dopamine transporter changes in our series of ad-p patients can indicate that dopaminergic presynaptic function is preserved in this population and that different dopaminergic changes such as postsynaptic ones, or different neurotransmitter alterations might underlie the extrapyramidal features in ad. |
2004-11-19 |
2023-08-12 |
Not clear |
| Ruth Reeves, Mona Thiruchelvam, Eric K Richfield, Deborah A Cory-Slecht. The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood. Toxicology and applied pharmacology. vol 200. issue 1. 2004-11-19. PMID:15451308. |
studies in this laboratory have found that repeated dosing with tdf in adult mice leads to the development and robust expression of behavioral sensitization, a response mediated by dopaminergic and glutamatergic neurotransmitter systems, and causing long-term changes in dopaminergic function. |
2004-11-19 |
2023-08-12 |
mouse |
| Rebecca L Roberts, Suzanne E Luty, Roger T Mulder, Peter R Joyce, Martin A Kenned. Association between cytochrome P450 2D6 genotype and harm avoidance. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 127B. issue 1. 2004-11-02. PMID:15108188. |
genetic polymorphisms within the serotonergic and dopaminergic neurotransmitter systems may be associated with heightened harm avoidance and novelty seeking. |
2004-11-02 |
2023-08-12 |
Not clear |
| Chan-Hyung Kim, Min-Seong Koo, Keun-Ah Cheon, Young-Hoon Ryu, Jong-Doo Lee, Hong-Shick Le. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder. European journal of nuclear medicine and molecular imaging. vol 30. issue 12. 2004-10-05. PMID:14513291. |
these findings suggest that the dopaminergic neurotransmitter system of the basal ganglia in patients with ocd could be involved in the pathophysiology of ocd. |
2004-10-05 |
2023-08-12 |
Not clear |
| Lavinia Albéri, Paola Sgadò, Horst H Simo. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development (Cambridge, England). vol 131. issue 13. 2004-08-30. PMID:15175251. |
despite a large mid-hindbrain deletion in double mutants null for both genes, mesencephalic dopaminergic (mda) neurons are induced, become postmitotic and acquire their neurotransmitter phenotype. |
2004-08-30 |
2023-08-12 |
mouse |
| Sarah M Clinton, James H Meador-Woodruf. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 7. 2004-08-02. PMID:15054476. |
abnormalities of psd95-like molecules and other intracellular signaling machinery may contribute to dysregulated communication between multiple neurotransmitter systems (such as glutamatergic and dopaminergic systems) that are potentially involved in the neurobiology of schizophrenia and affective disorders. |
2004-08-02 |
2023-08-12 |
Not clear |
| Andreas Hermann, Manfred Gerlach, Johannes Schwarz, Alexander Storc. Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration. Expert opinion on biological therapy. vol 4. issue 2. 2004-07-21. PMID:14998773. |
parkinson's disease (pd) is characterised by a continuous and selective loss of dopaminergic neurons in the substantia nigra pars compacta with a subsequent reduction of the neurotransmitter dopamine. |
2004-07-21 |
2023-08-12 |
Not clear |